09:58 AM EST - Ventripoint Diagnostics Ltd. : Has filed an application with Health Canada for approval of the expansion of the VMS heart analysis product to include right atrium, left atrium and left ventricle chambers of the heart. Ventripoint Diagnostics Ltd.
shares V.VPT are trading down $0.005 at $0.09.
